Clinical trial
Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
NCT05565313 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 22, 2022
- Completion date
- August 1, 2026
- Enrollment
- 900 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck carcinoma